ADORA2A and neoplasm: A natural ligand of A2AR, extracellular adenosine exerts its pro-tumor effects on a variety of cell types but primarily on tumor-infiltrating antigen-presenting cells and lymphocytes, as demonstrated by the restoration of antitumor immunity after genetic or pharmacological targeting of the extracellular adenosine pathway in preclinical tumor models.